Similar articles for PMID: 37945381

Year	Number of Results
1988	1
1989	1
1998	1
1999	1
2000	1
2001	1
2002	1
2004	1
2005	1
2006	4
2007	2
2010	1
2011	1
2012	5
2013	3
2014	6
2015	4
2016	4
2017	7
2018	3
2019	9
2020	10
2021	11
2022	11
2023	10
2024	5

1

The Hierarchy of SUVs: From Diagnostics to Therapeutics and the Pathway to Effective Theranostics.

Hofman MS. Hofman MS. J Nucl Med. 2023 Dec 1;64(12):1845-1847. doi: 10.2967/jnumed.123.266930. J Nucl Med. 2023. PMID: 37945381 No abstract available.

2

Theranostics: is it really a revolution? Evaluating a new term in medicine.

Wiesing U. Wiesing U. Med Health Care Philos. 2019 Dec;22(4):593-597. doi: 10.1007/s11019-019-09898-3. Med Health Care Philos. 2019. PMID: 30976948

3

Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges.

Alshehri S, Imam SS, Rizwanullah M, Akhter S, Mahdi W, Kazi M, Ahmad J. Alshehri S, et al. Pharmaceutics. 2020 Dec 24;13(1):24. doi: 10.3390/pharmaceutics13010024. Pharmaceutics. 2020. PMID: 33374391 Free PMC article. Review.

4

The Use of Medicinal Plant-Derived Metallic Nanoparticles in Theranostics.

Xulu JH, Ndongwe T, Ezealisiji KM, Tembu VJ, Mncwangi NP, Witika BA, Siwe-Noundou X. Xulu JH, et al. Pharmaceutics. 2022 Nov 10;14(11):2437. doi: 10.3390/pharmaceutics14112437. Pharmaceutics. 2022. PMID: 36365255 Free PMC article. Review.

5

Engineered Liposomes in Interventional Theranostics of Solid Tumors.

Kommineni N, Chaudhari R, Conde J, Tamburaci S, Cecen B, Chandra P, Prasad R. Kommineni N, et al. ACS Biomater Sci Eng. 2023 Aug 14;9(8):4527-4557. doi: 10.1021/acsbiomaterials.3c00510. Epub 2023 Jul 14. ACS Biomater Sci Eng. 2023. PMID: 37450683 Review.

6

Mitochondria-targeting theranostics.

Kang HC. Kang HC. Biomater Res. 2018 Nov 8;22:34. doi: 10.1186/s40824-018-0145-7. eCollection 2018. Biomater Res. 2018. PMID: 30455977 Free PMC article. Review.

7

Choice of Nanoparticles for Theranostics Engineering: Surface Coating to Nanovalves Approach.

Prasad R, Selvaraj K. Prasad R, et al. Nanotheranostics. 2024 Jan 1;8(1):12-32. doi: 10.7150/ntno.89768. eCollection 2024. Nanotheranostics. 2024. PMID: 38164501 Free PMC article. Review.

8

Theranostics for COVID-19 Antiviral Drugs: Prospects and Challenges for Worldwide Precision/Personalized Medicine.

Manóchio C, Torres-Loureiro S, Scudeler MM, Miwa B, Souza-Santos FC, Rodrigues-Soares F. Manóchio C, et al. OMICS. 2023 Jan;27(1):6-14. doi: 10.1089/omi.2022.0151. Epub 2023 Jan 4. OMICS. 2023. PMID: 36602768 Review.

9

Theranostics Using Antibodies and Antibody-Related Therapeutics.

Moek KL, Giesen D, Kok IC, de Groot DJA, Jalving M, Fehrmann RSN, Lub-de Hooge MN, Brouwers AH, de Vries EGE. Moek KL, et al. J Nucl Med. 2017 Sep;58(Suppl 2):83S-90S. doi: 10.2967/jnumed.116.186940. J Nucl Med. 2017. PMID: 28864618 Free article. Review.

10

Theranostics: rethinking postgenomic diagnostics.

Özdemir V, Cho WC. Özdemir V, et al. Expert Rev Mol Diagn. 2012 Nov;12(8):783-5. doi: 10.1586/erm.12.127. Expert Rev Mol Diagn. 2012. PMID: 23249192 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year